Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer
- PMID: 27693456
- DOI: 10.1016/j.canlet.2016.09.021
Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer
Abstract
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is capable of inducing apoptosis upon engagement of its death receptors (DRs) 4 and 5. TRAIL therapy has garnered intense interest as one of the most promising agents for cancer therapy, for its selective induction of tumor-cell apoptosis while low toxicity to most normal cells. However, a variety of breast cancer cell lines could be resistant to TRAIL-induced apoptosis. Absence of DR4 and DR5 on the breast cancer cell surface has been proposed to be critically involved in resistance to TRAIL and its agonistic antibodies. Moreover, endocytosis and autophagy in breast cancer cells could induce TRAIL resistance through downregulation of surface DR4/5. MicroRNAs (miRNAs), as endogenously expressed small non-coding RNAs, function as regulators of gene expression and involve tremendous biological processes including drug resistance. In this review, we highlight recent advances in the functional role of miRNAs in endocytosis and autophagy pathways. This review aims to present that, through regulation of critical molecules involved in autophagy and endocytosis, miRNAs could lead to mislocalization of DR4/5 in breast cancer cells and therefore play an important role in TRAIL-mediated apoptosis and TRAIL resistance.
Keywords: Breast cancer; Death receptors; MicroRNAs; TRAIL resistance.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.Oncotarget. 2015 Sep 22;6(28):25828-42. doi: 10.18632/oncotarget.4558. Oncotarget. 2015. PMID: 26304927 Free PMC article.
-
TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.Mol Cancer Res. 2008 Dec;6(12):1861-71. doi: 10.1158/1541-7786.MCR-08-0313. Mol Cancer Res. 2008. PMID: 19074831
-
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5.Oncotarget. 2013 Sep;4(9):1349-64. doi: 10.18632/oncotarget.1174. Oncotarget. 2013. PMID: 23988408 Free PMC article.
-
Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells.Cancer Gene Ther. 2013 Jan;20(1):33-7. doi: 10.1038/cgt.2012.81. Epub 2012 Nov 9. Cancer Gene Ther. 2013. PMID: 23138871 Review.
-
Spatial dynamics of TRAIL death receptors in cancer cells.Drug Resist Updat. 2015 Mar;19:13-21. doi: 10.1016/j.drup.2015.02.001. Epub 2015 Mar 9. Drug Resist Updat. 2015. PMID: 25840763 Review.
Cited by
-
CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner.Cancer Biol Med. 2021 Mar 12;18(2):569-86. doi: 10.20892/j.issn.2095-3941.2020.0196. Online ahead of print. Cancer Biol Med. 2021. PMID: 33710811 Free PMC article.
-
TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA.Cell Death Discov. 2017 Aug 21;3:17052. doi: 10.1038/cddiscovery.2017.52. eCollection 2017. Cell Death Discov. 2017. PMID: 29018571 Free PMC article.
-
Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.Oncotarget. 2017 Nov 3;8(68):112610-112622. doi: 10.18632/oncotarget.22614. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348850 Free PMC article.
-
Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox.Cancers (Basel). 2019 Jul 31;11(8):1087. doi: 10.3390/cancers11081087. Cancers (Basel). 2019. PMID: 31370269 Free PMC article. Review.
-
TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy.Int J Mol Sci. 2017 Jul 14;18(7):1523. doi: 10.3390/ijms18071523. Int J Mol Sci. 2017. PMID: 28708091 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical